| Literature DB >> 9755180 |
N V Kochneva-Pervukhova1, S V Paushkin, V V Kushnirov, B S Cox, M F Tuite, M D Ter-Avanesyan.
Abstract
The SUP35 gene of Saccharomyces cerevisiae encodes the polypeptide chain release factor eRF3. This protein (also called Sup35p) is thought to be able to undergo a heritable conformational switch, similarly to mammalian prions, giving rise to the cytoplasmically inherited Psi+ determinant. A dominant mutation (PNM2 allele) in the SUP35 gene causing a Gly58-->Asp change in the Sup35p N-terminal domain eliminates Psi+. Here we observed that the mutant Sup35p can be converted to the prion-like form in vitro, but such conversion proceeds slower than that of wild-type Sup35p. The overexpression of mutant Sup35p induced the de novo appearance of Psi+ cells containing the prion-like form of mutant Sup35p, which was able to transmit its properties to wild-type Sup35p both in vitro and in vivo. Our data indicate that this Psi+-eliminating mutation does not alter the initial binding of Sup35p molecules to the Sup35p Psi+-specific aggregates, but rather inhibits its subsequent prion-like rearrangement and/or binding of the next Sup35p molecule to the growing prion-like Sup35p aggregate.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9755180 PMCID: PMC1170908 DOI: 10.1093/emboj/17.19.5805
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598